Med. praxi. 2019;16(4):259-262 | DOI: 10.36290/med.2019.058

Novelties in the treatment of obesity

MUDr. Pavol Holéczy, CSc.
Katedra chirurgických oborů, LF Ostravské univerzity, Ostrava
Chirurgické oddělení, Vítkovická nemocnice, a. s., Ostrava

Obesity is a phenomenon of modern times. It is associated with numerous comorbidities. It affects virtually the entire planet. Treatment of obesity, both conservative and surgical, aims not only at weight reduction, but also, or, in particular, on the positive effect of comorbidities. Traditional procedures are well known to both lay and professional public. There are new definition of type and duration of physical acitivty. Newer possibilities in drug therapy provide recently introduced drugs on the Czech market (Mysimba® and Saxenda®). New surgical procedures also focus not only on weight reduction, but also on changes in body composition and the influence on comorbidities. Endoscopic procedures, which recently emerged, do not achieve the effectiveness and durability of surgical procedures, yet.

Keywords: obesity, comorbidity, physical aktivity, pharmacotherapy, endoskopy, surgery

Received: February 15, 2018; Accepted: April 24, 2018; Prepublished online: April 24, 2018; Published: October 1, 2019  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Holéczy P. Novelties in the treatment of obesity. Med. praxi. 2019;16(4):259-262. doi: 10.36290/med.2019.058.
Download citation

References

  1. WHO Obesity and overweight, Dostupné z: https://www.who.int/gho/ncd/risk_factors/overweight_text/en/
  2. Uerlich MF, Yumuk V, Finer N, et al. Obesity management in Europe: Current status and objectives for the future. Obes Facts 2016; (9): 273-283. Go to original source... Go to PubMed...
  3. Deitel M. The International Obesity Task Force and "globesity". Obes surg 2002; 12(5): 613-614. Go to original source... Go to PubMed...
  4. Farag YM, Gabala MR. Diabesity: an overview of a rising epidemic. Nephrol Dial Transplant 2011; 26(1): 28-35. Go to original source... Go to PubMed...
  5. Ryan DH, Kahan S. Guideline Recommendations for Obesity Management. Med Clin North Am 2018; 102(1): 49-63. Go to original source... Go to PubMed...
  6. Yumuk V, Tsigos C, Fried M, Schindler K, Busetto L, Micic D, Toplak H. European Guidelines for Obesity Management in Adults Obes Facts 2015; 8(6): 402-424. Go to original source... Go to PubMed...
  7. Fried M, Yumuk V, Oppert J-M, e al. Interdisciplinary European quidelines on metabolic and bariatric surgery. Obes Facts 2013; 6: 449-468. Go to original source... Go to PubMed...
  8. Seznam obezitologických pracovišť v České republice. Dostupné z: http//www.obesitas.cz
  9. ADA: Obesity Management for the Treatment of Type 2 Diabetes: Standards of Medical Care in Diabetes-2018. Diabetes care; 41(Suppl 1): S65-S72. Go to original source... Go to PubMed...
  10. Jakicic JM, Rogers RJ, Davis KK, Collins KA. Role of Physical Activity and Exercise in Treating Patients with Overweight and Obesity. Clin Chem. 2018; 64(1): 99-107. Go to original source... Go to PubMed...
  11. Coen PM, Carnero EA, Goodpaster BH. Exercise and Bariatric Surgery: An Effective Therapeutic Strategy. Exerc Sport Sci Rev. 2018 Oct; 46(4): 262-270. Go to original source... Go to PubMed...
  12. Churuangsuk C, Kherouf M, Combet E, Lean M. Low carobohydrate diet or overweight and obesity: a systematic review of the systematic reviews. Obes reviews, 2018; 19(12): 1700-1718. Go to original source... Go to PubMed...
  13. Hainer V, et al. Základy klinické obezitologie. 2. vyd. Praha: Grada Publishing 2011: s 277-280.
  14. Šrámková P. Novinky ve farmakoterapii obezity. Gastroent Hepatol 2018; 72(6): 495-500. Go to original source...
  15. Melissas J, ErenTaskin H, Peirasmakis D, et al. A Simple Food-Diverting Operation for Type 2 Diabetes Treatment. Preliminary Results in Humans with BMI 28-32 kg/m2. Obes Surg. 2017; 27(1): 22-29. Go to original source... Go to PubMed...
  16. Fried M, Dolezalova K, Chambers AP, et al. A novel approach to glycemic control in type 2 diabetes mellitus, partial jejunal diversion: pre-clinical to clinical pathway. BMJ Open Diabetes Res Care. 2017; 5(1): e000431. Go to original source... Go to PubMed...
  17. Machytka E, Bužga M, Zonča P, et al. Partial jejunal diversion using an incisionless magnetic anastomosis system: 1-year interim results in patients with obesity and diabetes. Gastrointest Endosc. 2017; 86(5): 904-912. Go to original source... Go to PubMed...
  18. Dargent J. Novel Endoscopic Management of Obesity Clin Endos 2016; 49(1): 30-36. Go to original source... Go to PubMed...
  19. Park JM. Role of Malabsorptive Endoscopic Procedures in Obesity Treatment. Clin Endosc 2017; 50: 26-30. Go to original source... Go to PubMed...
  20. Lee HL. Role of Restrictive Endoscopic Procedures in Obesity Treatment Clin Endosc 2017; 50: 17-20. Go to original source... Go to PubMed...
  21. Nyström M, Machytka E, Norén E, et al. Aspiration Therapy As a Tool to Treat Obesity: 1 - to 4-Year Results in a 201-Patient Multi-Center Post-Market European Registry Study. Obes Surg. 2018 [Epub ahead of print] Dostupné z: https://www.ncbi.nlm.nih.gov/pubmed/29388050. Go to original source... Go to PubMed...
  22. Alvarez-Cordero R. Will we still be cutting in the 21st century? Obes Surg 2005; 15(10): 1366-1367. Go to original source... Go to PubMed...




Medicine for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.